Verona Pharma (VRNA) News Today

$13.00
-0.36 (-2.69%)
(As of 05/17/2024 ET)
Verona Pharma plc Expected to Post FY2024 Earnings of ($1.36) Per Share (NASDAQ:VRNA)
Verona Pharma plc (NASDAQ:VRNA - Free Report) - HC Wainwright dropped their FY2024 earnings per share (EPS) estimates for Verona Pharma in a research report issued to clients and investors on Monday, May 13th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings per
Nicholas Investment Partners LP Trims Position in Verona Pharma plc (NASDAQ:VRNA)
Nicholas Investment Partners LP lessened its stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 85.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 169,126 shares of the company's stock after selling 993,863 shar
Verona Pharma (NASDAQ:VRNA) Price Target Cut to $30.00
Verona Pharma (NASDAQ:VRNA) Shares Down 5.8% on Analyst Downgrade
Verona Pharma (NASDAQ:VRNA) Shares Down 5.8% on Analyst Downgrade
Verona Pharma (NASDAQ:VRNA) Shares Down 4.3% on Insider Selling
Verona Pharma (NASDAQ:VRNA) Stock Price Down 4.3% on Insider Selling
Verona Pharma plc (NASDAQ:VRNA) Insider Kathleen A. Rickard Sells 36,248 Shares
Verona Pharma plc (NASDAQ:VRNA - Get Free Report) insider Kathleen A. Rickard sold 36,248 shares of the firm's stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $1.96, for a total transaction of $71,046.08. Following the sale, the insider now owns 2,621,552 shares of the company's stock, valued at $5,138,241.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Verona Pharma plc (NASDAQ:VRNA) is Vivo Capital LLC's 6th Largest Position
Vivo Capital LLC lowered its position in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 15.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,610,177 shares of the company's stock after sellin
Jennison Associates LLC Acquires 142,819 Shares of Verona Pharma plc (NASDAQ:VRNA)
Jennison Associates LLC grew its holdings in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 9.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,585,385 shares of the company's stock after
Verona Pharma (NASDAQ:VRNA) Stock Price Up 3.7% on Analyst Upgrade
Verona Pharma (NASDAQ:VRNA) Trading Up 3.7% on Analyst Upgrade
Verona Pharma (NASDAQ:VRNA) PT Raised to $36.00 at Piper Sandler
Piper Sandler increased their target price on shares of Verona Pharma from $31.00 to $36.00 and gave the stock an "overweight" rating in a report on Tuesday.
Verona Pharma (NASDAQ:VRNA) Shares Up 4.9%
Verona Pharma (NASDAQ:VRNA) Trading 4.9% Higher
American Century Companies Inc. Purchases Shares of 280,126 Verona Pharma plc (NASDAQ:VRNA)
American Century Companies Inc. purchased a new stake in Verona Pharma plc (NASDAQ:VRNA - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 280,126 shares of the company's stock, valued at approximate
Wellington Management Group LLP Acquires 164,268 Shares of Verona Pharma plc (NASDAQ:VRNA)
Wellington Management Group LLP lifted its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 3.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,467,571 shares of the
VRNA Apr 2024 17.500 call
VRNA Apr 2024 15.000 call
Verona Pharma (NASDAQ:VRNA) Trading Down 7.6%
Verona Pharma (NASDAQ:VRNA) Trading Down 7.6%
Adage Capital Partners GP L.L.C. Buys 208,100 Shares of Verona Pharma plc (NASDAQ:VRNA)
Adage Capital Partners GP L.L.C. grew its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 95.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 426,931 shares of the company's stock after buying an additional
Research Analysts Set Expectations for Verona Pharma plc's Q3 2024 Earnings (NASDAQ:VRNA)
Verona Pharma plc (NASDAQ:VRNA - Free Report) - Equities researchers at HC Wainwright reduced their Q3 2024 earnings estimates for Verona Pharma in a research report issued on Monday, March 4th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($0.32) per shar
Verona Pharma plc (NASDAQ:VRNA) Forecasted to Post Q4 2025 Earnings of ($0.01) Per Share
Verona Pharma plc (NASDAQ:VRNA - Free Report) - Investment analysts at HC Wainwright issued their Q4 2025 earnings estimates for shares of Verona Pharma in a research note issued to investors on Monday, March 4th. HC Wainwright analyst R. Selvaraju anticipates that the company will post earnings
Verona Pharma (NASDAQ:VRNA) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright restated a "buy" rating and issued a $32.00 target price on shares of Verona Pharma in a research note on Monday.
Andrew Fisher Joins Verona Pharma as General Counsel
Verona Pharma (NASDAQ:VRNA) Rating Reiterated by Wedbush
Wedbush reiterated an "outperform" rating and issued a $33.00 price objective on shares of Verona Pharma in a research note on Friday.
Verona Pharma earnings preview: what to expect
Avidity Partners Management LP Sells 124,200 Shares of Verona Pharma plc (NASDAQ:VRNA)
Avidity Partners Management LP cut its holdings in shares of Verona Pharma plc (NASDAQ:VRNA - Free Report) by 13.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 830,300 shares of the company's stock after se
When Will Verona Pharma plc (NASDAQ:VRNA) Turn A Profit?
Verona Pharma PLC ADR
Federated Hermes Inc. Has $40.65 Million Stock Position in Verona Pharma plc (NASDAQ:VRNA)
Federated Hermes Inc. lifted its holdings in Verona Pharma plc (NASDAQ:VRNA - Free Report) by 49.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,493,530 shares of the company's stock after buying an additional 822,832
VRNA Mar 2024 15.000 put
VRNA Jun 2024 30.000 call
Verona Pharma: A Few Points From The Bull And Bear Case
Get Verona Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter.

Obama’s Forever Term [exposed] (Ad)

America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.

Start streaming it now at no cost here

VRNA Media Mentions By Week

VRNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VRNA
News Sentiment

0.13

0.42

Average
Medical
News Sentiment

VRNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VRNA Articles
This Week

11

2

VRNA Articles
Average Week

Get Verona Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:VRNA) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners